Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C12H18ClN.ClH |
| Molecular Weight | 248.192 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(CC1=CC=CC=C1)NCCCCl
InChI
InChIKey=IDHNGYVCZUQHFV-UHFFFAOYSA-N
InChI=1S/C12H18ClN.ClH/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12;/h2-4,6-7,11,14H,5,8-10H2,1H3;1H
DescriptionCurator's Comment: description was created based on several sources, including, http://ec.europa.eu/health/documents/community-register/2000/200003093430/anx_3430_en.pdf
Curator's Comment: description was created based on several sources, including, http://ec.europa.eu/health/documents/community-register/2000/200003093430/anx_3430_en.pdf
Mefenorex or (+/-)N-(3-chloropropyl)-1-methyl-2-phenylethylamine is an N-alkylated analogue of amphetamine. The therapeutic efficacy of mefenorex as an adjunctive support in the treatment of obesity for limited periods of time, as well as its ability to be well tolerated, has been amply demonstrated. Mefenorex is considered to be racemic mixture, no available data regarding enantiospecific pharmacological activity of the compound.
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. | 2002 Apr |
|
| Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results. | 2002 May |
|
| Impaired cognition and attention in adults: pharmacological management strategies. | 2007 Feb |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29728
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
21776
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
100000086166
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110962
Created by
admin on Fri Dec 15 15:28:56 GMT 2023 , Edited by admin on Fri Dec 15 15:28:56 GMT 2023
|
PRIMARY | |||
|
226-985-9
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
m7140
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | Merck Index | ||
|
C000450
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
SUB03115MIG
Created by
admin on Fri Dec 15 15:28:56 GMT 2023 , Edited by admin on Fri Dec 15 15:28:56 GMT 2023
|
PRIMARY | |||
|
133749
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
6X1N18AU15
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
C77848
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | |||
|
5586-87-8
Created by
admin on Fri Dec 15 15:28:56 GMT 2023 , Edited by admin on Fri Dec 15 15:28:56 GMT 2023
|
PRIMARY | |||
|
236179
Created by
admin on Fri Dec 15 15:28:57 GMT 2023 , Edited by admin on Fri Dec 15 15:28:57 GMT 2023
|
PRIMARY | RxNorm |
ACTIVE MOIETY
SUBSTANCE RECORD
